Clinical trial
A Prospective, Multicenter, Randomized Controlled Trial on the Efficacy and Safety of Perfluorohexyloctane Eye Drops Versus 0.1% Sodium Hyaluronate Eye Drops in the Treatment of Video Display Terminal-associated Dry Eye
NCT07679685 is registered in ClinicalTrials.gov with Beijing Tongren Hospital as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- A Prospective, Multicenter, Randomized Controlled Trial on the Efficacy and Safety of Perfluorohexyloctane Eye Drops Versus 0.1% Sodium Hyaluronate Eye Drops in the Treatment of Video Display Terminal-associated Dry Eye
- Lead sponsor
- Beijing Tongren Hospital
- Phase
- Phase 4
- Overall status
- Not yet recruiting
- Start date
- June 30, 2026
- Completion date
- April 30, 2027
- Enrollment
- 159 (estimated)
- Sites
- 9
Conditions
As the registry lists them; a condition with its own page is linked.
dry eye